Transcept Pharmaceuticals, Inc. (TSPT) Tops Q3 EPS by 19c

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) reported Q3 EPS of $0.25, $0.19 better than the analyst estimate of $0.06. Revenue for the quarter came in at $10.44 million versus the consensus estimate of $8.37 million.

For earnings history and earnings-related data on Transcept Pharmaceuticals, Inc. (TSPT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Pan American Silver (PAAS) Misses Q2 EPS by 19c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c